-
1
-
-
0036865059
-
Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): A review
-
DOI 10.1093/humupd/8.6.559
-
Delvigne A, Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Update 2002;8:559-577 (Review). (Pubitemid 35452781)
-
(2002)
Human Reproduction Update
, vol.8
, Issue.6
, pp. 559-577
-
-
Delvinge, A.1
Rozenberg, S.2
-
2
-
-
38049170879
-
The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: A prospective randomized controlled study
-
[Epub 2007 Apr 26]
-
Engmann L, DiLuigi A, Schmidt D, Nulsen J, Maier D, Benadiva C. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study. Fertil Steril 2008;89:84-91 [Epub 2007 Apr 26].
-
(2008)
Fertil Steril
, vol.89
, pp. 84-91
-
-
Engmann, L.1
Diluigi, A.2
Schmidt, D.3
Nulsen, J.4
Maier, D.5
Benadiva, C.6
-
3
-
-
33747059580
-
Rescue of corpus luteum function with peri-ovulatory HCG supplementation in IVF/ICSI GnRH antagonist in which ovulation was triggered with a GnRH agonist: A pilot study
-
Humaidan P, Bungum L, Bungum M, Yding Andersen C. Rescue of corpus luteum function with peri-ovulatory HCG supplementation in IVF/ICSI GnRH antagonist in which ovulation was triggered with a GnRH agonist: a pilot study. Reprod Biomed Online 2006;13:173-178.
-
(2006)
Reprod Biomed Online
, vol.13
, pp. 173-178
-
-
Humaidan, P.1
Bungum, L.2
Bungum, M.3
Yding Andersen, C.4
-
4
-
-
72049113529
-
1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: A prospective, randomized, controlled study
-
Feb 5 [Epub ahead of print]
-
Humaidan P, Bredkjær HE, Westergaard LG, Yding Andersen C. 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study. Fertil Steril 2009 Feb 5 [Epub ahead of print].
-
(2009)
Fertil Steril
-
-
Humaidan, P.1
Bredkjær, H.E.2
Westergaard, L.G.3
Yding Andersen, C.4
-
5
-
-
85056986589
-
Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist ART cycles. A systematic review and meta-analysis
-
Abstracts of the Amsterdam, the Netherlands, 28 June 1 July
-
Youssef M, Griesinger G, Van Wely M, AL-inany H, van der Veen F. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist ART cycles. A systematic review and meta-analysis. Abstracts of the 25th Annual Meeting of ESHRE, Amsterdam, the Netherlands, 28 June 1 July, 2009. p. I115.
-
(2009)
25th Annual Meeting of ESHRE
-
-
Youssef, M.1
Griesinger, G.2
Van Wely, M.3
Al-Inany, H.4
Van Der Veen, F.5
|